Association between the ERCC5 asp1104his polymorphism and cancer risk: A meta-analysis

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Zhu, Mei Ling ^a,b   Wang, Mengyun ^a,b   Cao, Zhi Gang ^a,b   He, Jing ^a,b   Shi, Ting Yan ^a,b   Xia, Kai Qin ^a,b   Qiu, Li Xin ^a,b   Wei, Qing Yi ^a,c  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; ESTERASE; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 5; HISTIDINE; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER RISK; COLORECTAL CANCER; ERCC5 GENE; ETHNICITY; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; NONHODGKIN LYMPHOMA; RECESSIVE INHERITANCE; SKIN CANCER;

DNA-BINDING PROTEINS; ENDONUCLEASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 84864000719     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036293     Document Type: Article

References (122)

1. Wood RD, (1999) DNA damage recognition during nucleotide excision repair in mammalian cells. Biochimie 81: 39-44.
2. Wakasugi M, Reardon JT, Sancar A, (1997) The non-catalytic function of XPG protein during dual incision in human nucleotide excision repair. J Biol Chem 272: 16030-16034.
3. O'Donovan A, Davies AA, Moggs JG, West SC, Wood RD, (1994) XPG endonuclease makes the 3′ incision in human DNA nucleotide excision repair. Nature 371: 432-435.
4. Scherly D, Nouspikel T, Corlet J, Ucla C, Bairoch A, et al. (1993) Complementation of the DNA repair defect in xeroderma pigmentosum group G cells by a human cDNA related to yeast RAD2. Nature 363: 182-185.
5. Wakasugi M, Reardon JT, Sancar A, (1997) The Non-catalytic function of XPG protein during dual incision in human nucleotide excision repair. Journal of Biological Chemistry 272: 16030-16034.
6. Constantinou A, Gunz D, Evans E, Lalle P, Bates PA, et al. (1999) Conserved residues of human XPG protein important for nuclease activity and function in nucleotide excision repair. J Biol Chem 274: 5637-5648.
7. Iyer N, Reagan MS, Wu KJ, Canagarajah B, Friedberg EC, (1996) Interactions involving the human RNA polymerase II transcription/nucleotide excision repair complex TFIIH, the nucleotide excision repair protein XPG, and Cockayne syndrome group B (CSB) protein. Biochemistry 35: 2157-2167.
8. Araujo SJ, Nigg EA, Wood RD, (2001) Strong functional interactions of TFIIH with XPC and XPG in human DNA nucleotide excision repair, without a preassembled repairosome. Molecular and Cellular Biology 21: 2281-2291.
9. Thorel F, Constantinou A, Dunand-Sauthier I, Nouspikel T, Lalle P, et al. (2004) Definition of a short region of XPG necessary for TFIIH interaction and stable recruitment to sites of UV damage. Mol Cell Biol 24: 10670-10680.
10. He ZG, Henricksen LA, Wold MS, Ingles CJ, (1995) Rpa Involvement in the Damage-Recognition and Incision Steps of Nucleotide Excision-Repair. Nature 374: 566-569.
11. Dunand-Sauthier I, Hohl M, Thorel F, Jaquier-Gubler P, Clarkson SG, et al. (2005) The spacer region of XPG mediates recruitment to nucleotide excision repair complexes and determines substrate specificity. Journal of Biological Chemistry 280: 7030-7037.
12. Hofmann K, (2009) Ubiquitin-binding domains and their role in the DNA damage response. DNA Repair 8: 544-556.
13. Gary R, Ludwig DL, Cornelius HL, MacInnes MA, Park MS, (1997) The DNA repair endonuclease XPG binds to proliferating cell nuclear antigen (PCNA) and shares sequence elements with the PCNA binding regions of FEN-1 and cyclin-dependent kinase inhibitor p21. Journal of Biological Chemistry 272: 24522-24529.
14. Fagbemi AF, Orelli B, Scharer OD, (2011) Regulation of endonuclease activity in human nucleotide excision repair. DNA Repair 10: 722-729.
15. Hanawalt PC, (2001) Controlling the efficiency of excision repair. Mutat Res 485: 3-13.
16. Emmert S, Slor H, Busch DB, Batko S, Albert RB, et al. (2002) Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients. J Invest Dermatol 118: 972-982.
17. Ito S, Kuraoka I, Chymkowitch P, Compe E, Takedachi A, et al. (2007) XPG stabilizes TFIIH, allowing transactivation of nuclear receptors: implications for Cockayne syndrome in XP-G/CS patients. Mol Cell 26: 231-243.
18. Scharer OD, (2008) Hot topics in DNA repair: the molecular basis for different disease states caused by mutations in TFIIH and XPG. DNA Repair (Amst) 7: 339-344.
19. Lee SK, Yu SL, Prakash L, Prakash S, (2002) Requirement of yeast RAD2, a homolog of human XPG gene, for efficient RNA polymerase II transcription. implications for Cockayne syndrome. Cell 109: 823-834.
20. Klungland A, Hoss M, Gunz D, Constantinou A, Clarkson SG, et al. (1999) Base excision repair of oxidative DNA damage activated by XPG protein. Molecular Cell 3: 33-42.
21. Bessho T, (1999) Nucleotide excision repair 3′ endonuclease XPG stimulates the activity of base excision repairenzyme thymine glycol DNA glycosylase. Nucleic Acids Res 27: 979-983.
22. Koeppel F, Poindessous V, Lazar V, Raymond E, Sarasin A, et al. (2004) Irofulven cytotoxicity depends on transcription-coupled nucleotide excision repair and is correlated with XPG expression in solid tumor cells. Clinical Cancer Research 10: 5604-5613.
23. Cheng L, Sturgis EM, Eicher SA, Spitz MR, Wei Q, (2002) Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck. Cancer 94: 393-397.
24. Cheng L, Spitz MR, Hong WK, Wei Q, (2000) Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis. Carcinogenesis 21: 1527-1530.
25. Bartolucci R, Wei J, Sanchez JJ, Perez-Roca L, Chaib I, et al. (2009) XPG mRNA expression levels modulate prognosis in resected non-small-cell lung cancer in conjunction with BRCA1 and ERCC1 expression. Clin Lung Cancer 10: 47-52.
26. Walsh CS, Ogawa S, Karahashi H, Scoles DR, Pavelka JC, et al. (2008) ERCC5 is a novel biomarker of ovarian cancer prognosis. Journal of Clinical Oncology 26: 2952-2958.
27. Kraemer KH, Lee MM, Andrews AD, Lambert WC, (1994) The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol 130: 1018-1021.
28. Emmert S, Schneider TD, Khan SG, Kraemer KH, (2001) The human XPG gene: gene architecture, alternative splicing and single nucleotide polymorphisms. Nucleic Acids Res 29: 1443-1452.
29. Li Y, Gu S, Wu Q, Li Y, Fu X, et al. (2007) No association of ERCC1 C8092A and T19007C polymorphisms to cancer risk: a meta-analysis. European journal of human genetics: EJHG 15: 967-973.
30. Cao C, Zhang Y-M, Wang R, Sun S-F, Chen Z-B, et al. (2011) Excision repair cross complementation group 1 polymorphisms and lung cancer risk: a meta-analysis. Chinese Medical Journal 124: 2203-2208.
31. Vineis P, Manuguerra M, Kavvoura FK, Guarrera S, Allione A, et al. (2009) A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. Journal of the National Cancer Institute 101: 24-36.
32. Kiyohara C, Takayama K, Nakanishi Y, (2010) Lung cancer risk and genetic polymorphisms in DNA repair pathways: a meta-analysis. Journal of nucleic acids 2010: 701760.
33. Qian B, Zhang H, Zhang L, Zhou X, Yu H, et al. (2011) Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung cancer (Amsterdam, Netherlands) 73: 138-146.
34. Qiu L, Wang Z, Shi X, Wang Z, (2008) Associations between XPC polymorphisms and risk of cancers: A meta-analysis. European journal of cancer (Oxford, England: 1990) 44: 2241-2253.
35. Stern MC, Lin J, Figueroa JD, Kelsey KT, Kiltie AE, et al. (2009) Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer. Cancer Research 69: 6857-6864.
36. Zheng W, Cong X-F, Cai W-H, Yang S, Mao C, et al. (2011) Current evidences on XPC polymorphisms and breast cancer susceptibility: a meta-analysis. Breast cancer research and treatment 128: 811-815.
37. Wang F, Chang D, Hu F-l, Sui H, Han B, et al. (2008) DNA repair gene XPD polymorphisms and cancer risk: a meta-analysis based on 56 case-control studies. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 17: 507-517.
38. Li C, Jiang Z, Liu X, (2009) XPD Lys(751)Gln and Asp (312)Asn polymorphisms and bladder cancer risk: a meta-analysis. Molecular biology reports 37: 301-309.
39. Mocellin S, Verdi D, Nitti D, (2009) DNA repair gene polymorphisms and risk of cutaneous melanoma: a systematic review and meta-analysis. Carcinogenesis 30: 1735-1743.
40. Pabalan N, Francisco-Pabalan O, Sung L, Jarjanazi H, Ozcelik H (2010) Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer. Breast cancer research and treatment 124: 531-541.
41. Qiu L-X, Yao L, Zhang J, Zhu X-D, Zhao X-M, et al. (2010) XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects. Breast cancer research and treatment 124: 229-235.
42. Chen B, Zhou Y, Yang P, Wu X-T, (2011) ERCC2 Lys751Gln and Asp312Asn polymorphisms and gastric cancer risk: a meta-analysis. Journal of cancer research and clinical oncology 137: 939-946.
43. Yuan L, Cui D, Zhao E-J, Jia C-Z, Wang L-D, et al. (2011) XPD Lys751Gln polymorphism and esophageal cancer risk: a meta-analysis involving 2288 cases and 4096 controls. World journal of gastroenterology: WJG 17: 2343-2348.
44. Ding D-P, He X-F, Zhang Y (2011) Lack of association between XPG Asp1104His and XPF Arg415Gln polymorphism and breast cancer risk: a meta-analysis of case-control studies. Breast cancer research and treatment 129: 203-209.
45. The International HapMap Consortium, (2003) The International HapMap Project. Nature 426: 789-796.
46. Holm K, Melum E, Franke A, Karlsen TH, (2010) SNPexp- A web tool for calculating and visualizing correlation between HapMap genotypes and gene expression levels. BMC bioinformatics 11: 600-604.
47. Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazlsy C, et al. (2007) Relative impact of nucleotide and copy number variation on gene phenotypes. Science 315: 848-853.
48. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
49. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
50. Egger M, Smith GD, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 315: 629-634.
51. Chen M, Kamat AM, Huang M, Grossman HB, Dinney CP, et al. (2007) High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk. Carcinogenesis 28: 2160-2165.
52. Cui Y, Morgenstern H, Greenland S, Tashkin DP, Mao J, et al. (2006) Polymorphism of Xeroderma Pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus. Int J Cancer 118: 714-720.
53. Hung RJ, Baragatti M, Thomas D, McKay J, Szeszenia-Dabrowska N, et al. (2007) Inherited predisposition of lung cancer: A hierarchical modeling approach to DNA repair and cell cycle control pathways. Cancer Epidemiology Biomarkers & Prevention 16: 2736-2744.
54. Joshi AD, Corral R, Siegmund KD, Haile RW, Le Marchand L, et al. (2009) Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways and colorectal cancer risk. Carcinogenesis 30: 472-479.
55. Liu YH, Scheurer ME, El-Zein R, Cao YM, Do KA, et al. (2009) Association and Interactions between DNA Repair Gene Polymorphisms and Adult Glioma. Cancer Epidemiology Biomarkers & Prevention 18: 204-214.
56. Michiels S, Danoy P, Dessen P, Bera A, Boulet T, et al. (2007) Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers. Carcinogenesis 28: 1731-1739.
57. Mort R, Mo L, McEwan C, Melton DW, (2003) Lack of involvement of nucleotide excision repair gene polymorphisms in colorectal cancer. British Journal of Cancer 89: 333-337.
58. Wen H, Ding Q, Fang ZJ, Xia GW, Fang J, (2009) Population study of genetic polymorphisms and superficial bladder cancer risk in Han-Chinese smokers in Shanghai. International Urology and Nephrology 41: 855-864.
59. An J, Liu Z, Hu Z, Li G, Wang LE, et al. (2007) Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev 16: 1633-1638.
60. Weiss JM, Weiss NS, Ulrich CM, Doherty JA, Chen C, et al. (2006) Nucleotide excision repair genotype and the incidence of endometrial cancer: Effect of other risk factors on the association. Gynecologic Oncology 103: 891-896.
61. Rouissi K, Ouerhani S, Hamrita B, Bougatef K, Marrakchi R, et al. (2011) Smoking and polymorphisms in xenobiotic metabolism and DNA repair genes are additive risk factors affecting bladder cancer in Northern Tunisia. Pathology and Oncology Research 17: 879-886.
62. Berhane N, Sobti RC, Mahdi SA, (2012) DNA repair genes polymorphism (XPG and XRCC1) and association of prostate cancer in a north Indian population. Molecular biology reports 39: 2471-2479.
63. Goncalves FT, Francisco G, de Souza SP, Luiz OC, Festa-Neto C, et al. (2011) European ancestry and polymorphisms in DNA repair genes modify the risk of melanoma: A case-control study in a high UV index region in Brazil. Journal of Dermatological Science 64: 59-66.
64. He X, Ye F, Zhang J, Cheng Q, Shen J, et al. (2008) Susceptibility of XRCC3, XPD, and XPG genetic variants to cervical carcinoma. Pathobiology 75: 356-363.
65. Jeon HS, Kim KM, Park SH, Lee SY, Choi JE, et al. (2003) Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer. Carcinogenesis 24: 1677-1681.
66. McKean-Cowdin R, Barnholtz-Sloan J, Inskip PD, Ruder AM, Butler M, et al. (2009) Associations between Polymorphisms in DNA Repair Genes and Glioblastoma. Cancer Epidemiology Biomarkers & Prevention 18: 1118-1126.
67. Smith TR, Levine EA, Freimanis RI, Akman SA, Allen GO, et al. (2008) Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis 29: 2132-2138.
68. Wen SX, Tang PZ, Zhang XM, Zhao D, Guo YL, et al. (2006) Association between genetic polymorphism in xeroderma pigmentosum G gene and risks of laryngeal and hypopharyngeal carcinomas. Acta Academiae Medicinae Sinicae 28: 703-706.
69. Kumar R, Hoglund L, Zhao C, Forsti A, Snellman E, et al. (2003) Single nucleotide polymorphisms in the XPG gene: determination of role in DNA repair and breast cancer risk. Int J Cancer 103: 671-675.
70. Mechanic LE, Millikan RC, Player J, de Cotret AR, Winkel S, et al. (2006) Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study. Carcinogenesis 27: 1377-1385.
71. Shen J, Desai M, Agrawal M, Kennedy DO, Senie RT, et al. (2006) Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer. Cancer Epidemiology Biomarkers and Prevention 15: 1614-1619.
72. Crew KD, Gammon MD, Terry MB, Fang FZ, Zablotska LB, et al. (2007) Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts, and breast cancer risk. Cancer Epidemiology Biomarkers and Prevention 16: 2033-2041.
73. Jorgensen TJ, Visvanathan K, Ruczinski I, Thuita L, Hoffman S, et al. (2007) Breast cancer risk is not associated with polymorphic forms of xeroderma pigmentosum genes in a cohort of women from Washington County, Maryland. Breast Cancer Res Treat 101: 65-71.
74. Smith TR, Levine EA, Freimanis RI, Akman SA, Allen GO, et al. (2008) Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis 29: 2132-2138.
75. Rajaraman P, Bhatti P, Doody MM, Simon SL, Weinstock RM, et al. (2008) Nucleotide excision repair polymorphisms may modify ionizing radiation-related breast cancer risk in US radiologic technologists. International Journal of Cancer 123: 2713-2716.
76. Hsu MS, Yu JC, Wang HW, Chen ST, Hsiung CN, et al. (2010) Synergistic Effects of Polymorphisms in DNA Repair Genes and Endogenous Estrogen Exposure on Female Breast Cancer Risk. Annals of Surgical Oncology 17: 760-771.
77. Blankenburg S, Konig IR, Moessner R, Laspe P, Thoms KM, et al. (2005) No association between three xeroderma pigmentosum group C and one group G gene polymorphisms and risk of cutaneous melanoma. Eur J Hum Genet 13: 253-255.
78. Li C, Hu Z, Liu Z, Wang LE, Strom SS, et al. (2006) Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis. Cancer Epidemiol Biomarkers Prev 15: 2526-2532.
79. Povey JE, Darakhshan F, Robertson K, Bisset Y, Mekky M, et al. (2007) DNA repair gene polymorphisms and genetic predisposition to cutaneous melanoma. Carcinogenesis 28: 1087-1093.
80. Figl A, Scherer D, Nagore E, Bermejo JL, Botella-Estrada R, et al. (2010) Single-nucleotide polymorphisms in DNA-repair genes and cutaneous melanoma. Mutation Research- Genetic Toxicology and Environmental Mutagenesis 702: 8-16.
81. Ibarrola-Villava M, Pena-Chilet M, Fernandez LP, Aviles JA, Mayor M, et al. (2011) Genetic polymorphisms in DNA repair and oxidative stress pathways associated with malignant melanoma susceptibility. European Journal of Cancer.
82. Thirumaran RK, Bermejo JL, Rudnai P, Gurzau E, Koppova K, et al. (2006) Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin. Carcinogenesis 27: 1676-1681.
83. Wang LE, Li C, Strom SS, Goldberg LH, Brewster A, et al. (2007) Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression. Clin Cancer Res 13: 6532-6539.
84. Sanyal S, Festa F, Sakano S, Zhang Z, Steineck G, et al. (2004) Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25: 729-734.
85. Garcia-Closas M, Malats N, Real FX, Welch R, Kogevinas M, et al. (2006) Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 15: 536-542.
86. Wu X, Gu J, Grossman HB, Amos CI, Etzel C, et al. (2006) Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet 78: 464-479.
87. Narter KF, Ergen A, Agachan B, Gormus U, Timirci O, et al. (2009) Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1). Anticancer Res 29: 1389-1393.
88. Rouissi K, Ouerhani S, Hamrita B, Bougatef K, Marrakchi R, et al. (2011) Smoking and Polymorphisms in Xenobiotic Metabolism and DNA Repair Genes are Additive Risk Factors Affecting Bladder Cancer in Northern Tunisia. Pathol Oncol Res.
89. Shen M, Berndt SI, Rothman N, Demarini DM, Mumford JL, et al. (2005) Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. Int J Cancer 116: 768-773.
90. Sakiyama T, Kohno T, Mimaki S, Ohta T, Yanagitani N, et al. (2005) Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk. Int J Cancer 114: 730-737.
91. Hung RJ, Christiani DC, Risch A, Popanda O, Haugen A, et al. (2008) International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev 17: 3081-3089.
92. Chang JS, Wrensch MR, Hansen HM, Sison JD, Aldrich MC, et al. (2008) Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. Int J Cancer 123: 2095-2104.
93. Sugimura T, Kumimoto H, Tohnai I, Fukui T, Matsuo K, et al. (2006) Gene-environment interaction involved in oral carcinogenesis: Molecular epidemiological study for metabolic and DNA repair gene polymorphisms. Journal of Oral Pathology and Medicine 35: 11-18.
94. Abbasi R, Ramroth H, Becher H, Dietz A, Schmezer P, et al. (2009) Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes. Int J Cancer 125: 1431-1439.
95. Hongxia M, Hongping Y, Zhensheng L, Li EW, Erich MS, et al. (2011) Polymorphisms of XPG/ERCC5 and risk of squamous cell carcinoma of the head and neck. Pharmacogenetics and Genomics.
96. Pardini B, Naccarati A, Novotny J, Smerhovsky Z, Vodickova L, et al. (2008) DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic. Mutat Res 638: 146-153.
97. Gil J, Ramsey D, Stembalska A, Karpinski P, Pesz KA, et al. (2011) The C/A polymorphism in intron 11 of the XPC gene plays a crucial role in the modulation of an individual's susceptibility to sporadic colorectal cancer. Mol Biol Rep.
98. Canbay E, Cakmakoglu B, Zeybek U, Sozen S, Cacina C, et al. (2011) Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population. Curr Med Res Opin 27: 1295-1302.
99. Shen M, Zheng T, Lan Q, Zhang Y, Zahm SH, et al. (2006) Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut. Hum Genet 119: 659-668.
100. Hill DA, Wang SS, Cerhan JR, Davis S, Cozen W, et al. (2006) Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes. Blood 108: 3161-3167.
101. Shen M, Purdue MP, Kricker A, Lan Q, Grulich AE, et al. (2007) Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia. Haematologica 92: 1180-1185.
102. Hussain SK, Mu LN, Cai L, Chang SC, Park SL, et al. (2009) Genetic variation in immune regulation and DNA repair pathways and stomach cancer in China. Cancer Epidemiol Biomarkers Prev 18: 2304-2309.
103. Canbay E, Agachan B, Gulluoglu M, Isbir T, Balik E, et al. (2010) Possible associations of APE1 polymorphism with susceptibility and HOGG1 polymorphism with prognosis in gastric cancer. Anticancer Res 30: 1359-1364.
104. Weiss JM, Weiss NS, Ulrich CM, Doherty JA, Voigt LF, et al. (2005) Interindividual variation in nucleotide excision repair genes and risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 14: 2524-2530.
105. Doherty JA, Weiss NS, Fish S, Fan W, Loomis MM, et al. (2011) Polymorphisms in Nucleotide Excision Repair Genes and Endometrial Cancer Risk. Cancer Epidemiol Biomarkers Prev.
106. Hooker S, Bonilla C, Akereyeni F, Ahaghotu C, Kittles RA, (2008) NAT2 and NER genetic variants and sporadic prostate cancer susceptibility in African Americans. Prostate Cancer Prostatic Dis 11: 349-356.
107. Le Morvan V, Longy M, Bonaiti-Pellie C, Bui B, Houede N, et al. (2006) Genetic polymorphisms of the XPG and XPD nucleotide excision repair genes in sarcoma patients. Int J Cancer 119: 1732-1735.
108. Biason P, Hattinger CM, Innocenti F, Talamini R, Alberghini M, et al. (2011) Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy. Pharmacogenomics J.
109. El-Zein R, Monroy CM, Etzel CJ, Cortes AC, Xing Y, et al. (2009) Genetic polymorphisms in DNA repair genes as modulators of Hodgkin disease risk. Cancer 115: 1651-1659.
110. Rajaraman P, Hutchinson A, Wichner S, Black PM, Fine HA, et al. (2010) DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol 12: 37-48.
111. Pan J, Lin J, Izzo JG, Liu Y, Xing J, et al. (2009) Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway Carcinogenesis 30: 785-792.
112. Li LM, Zeng XY, Ji L, Fan XJ, Li YQ, et al. (2010) [Association of XPC and XPG polymorphisms with the risk of hepatocellular carcinoma]. Zhonghua Gan Zang Bing Za Zhi 18: 271-275.
113. Vodicka P, Stetina R, Polakova V, Tulupova E, Naccarati A, et al. (2007) Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis 28: 657-664.
114. Friedberg EC, (2003) DNA damage and repair. Nature 421: 436-440.
115. Bodmer W, Bonilla C, (2008) Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 40: 695-701.
116. Ng PC, Henikoff S, (2001) Predicting deleterious amino acid substitutions. Genome Res 11: 863-874.
117. Rafnar T, Sulem P, Stacey SN, Geller F, Gudmundsson J, et al. (2009) Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nature genetics 41: 221-227.
118. Gudmundsson J, Sulem P, Manolescu A, Amundadottir LT, Gudbjartsson D, et al. (2007) Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nature genetics 39: 631-637.
119. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, et al. (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nature genetics 39: 645-649.
120. Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, et al. (2007) Multiple regions within 8q24 independently affect risk for prostate cancer. Nature genetics 39: 638-644.
121. Tomlinson I, Webb E, Carvajal-Carmona L, Broderick P, Kemp Z, et al. (2007) A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nature genetics 39: 984-988.
122. Kiemeney LA, Thorlacius S, Sulem P, Geller F, Aben KKH, et al. (2008) Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nature genetics 40: 1307-1312.